Skip to main content
Clinical Trials/JPRN-UMIN000031976
JPRN-UMIN000031976
Completed
N/A

Exploratory Study of Genetic Factors Related to the Inhibitory Effect of Tolvaptan on Increased Kidney Volume in Patients with Autosomal Dominant Polycystic Kidney Disease - To explore genome biomarkers for Tolvaptan efficacy in ADPKD

Otsuka Pharmaceutical Co.,Ltd.0 sites890 target enrollmentMarch 29, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Autosomal Dominant Polycystic Kidney Disease
Sponsor
Otsuka Pharmaceutical Co.,Ltd.
Enrollment
890
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 29, 2018
End Date
March 30, 2019
Last Updated
2 years ago
Study Type
Others,meta-analysis etc
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who did not participate in extension Trial(Refer to ClinicalTrials.gov:NCT01280721 or NCT01214421\)

Outcomes

Primary Outcomes

Not specified

Similar Trials